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Summary.-The influence of some biogenic amines and amine-receptor-blocking
drugs in the growth rate of human colorectal carcinomas propagated as s.c. xeno-
grafts in immune-deprived mice was studied. In mice treated with adrenaline, a
/3-adrenergic agonist, the growth ofxenografts was suppressed for2 days, after which
growth was resumed at a rate similar to that in control animals. Treatment with the
phosphodiesterase inhibitor theophylline prolonged the adrenaline-induced inhibi-
tion of growth. Treatment with the /-adrenergic antagonist sotalol or practolol
increased the rate of tumour growth. Treatment with either serotonin or the
histamine H2-receptor agonist Dimiprit had no effect on tumour growth rate.
However, the antiserotoninergic drug BW 501C and the histamine H2-receptor
antagonist cimetidine each caused short-term suppression of tumour growth.
IT IS NOW well recognized that biogenic
amines are able to exert short-term in-
fluences, both excitatory and inhibiting,
on cell proliferation in various malignant
and non-malignant tissues (Bullough &
Laurence, 1966; Byron, 1972, 1977;
Epifanova & Tchoumak, 1963; Hadden
et al., 1970; Hunt & Tutton, 1976; Klein,
1977; Leeson & Voaden, 1970, Norrby,
1973; Tutton, 1974, 1976; Tutton &
Barkla, 1976, 1977, 1978a, b; Tutton &
Helme, 1974). However, the influence of
these ubiquitous agents on cell prolifera-
tion in human tumours and on volumetric
changes in neoplasms does not appear to
have been reported. Serial observations of
human tumours growing as xenografts in
immune-suppressed mice provide an
opportunity to explore the hormonal
factors controlling the progression of
cancer, without the constraints necessarily
surrounding human experimentation. This
paper reports some preliminary observa-
tions on the influence of biogenic amines
and amine-receptor-blocking drugs on the
growth of human colorectal carcinomas in
xenografts.
MATERIALS AND METHODS
Xenograft technique.-Female CBA/lac
mice were immunosuppressed by the tech-
nique of Steel et al. (1978). This technique
involves thymectomy followed 2 weeks later
by injection ofcytosine arabinoside (Cytostar,
the Upjohn Company) at a dose of200 mg/kg
and, after a further 24 h, the administration
of 9 Gy of whole-body irradiation from a
60Co source. Pre-treatment with cytosine
arabinoside obviates the need for marrow
reconstitution after irradiation. Small frag-
ments (2-3 mm in greatest linear dimension)
of tumours HXK4 and HXK7 (Nowak et al.,
1978) were implanted s.c. in each flank ofthe
mice. Tumour HXK4 was originally propa-
gated from a moderately well differentiated
carcinoma of the rectosigmoid junction, and
tumour HXK7 was originally propagated
from a moderate to poorly differentiated
carcinoma ofthe rectum.
Tumour measurement.-Starting on the
20th day after implantation, tumours were
measured every 1-2 days. The largest and
* Present address: Department of Anatomy, Mlonaslh University, Clayton 3168, Victoria, Australia.7P. J. M. TUTTON AND G. G. STEEL
smallest superficial diameters were recorded,
and the tumour volume was calculated as
(mean diameter)3ii/6. The daily volume of
each tumour (Vt) was divided by the volume
of that tumour on the first day of measure-
ment (VO) to obtain the relative tumour
volume. The mean and s.e. of this quotient
were then plotted as a function of time after
the first measurement of each control and
experimental group of tumours. The relative
volume was calculated because inter-tumour
variation in this parameter arises only during
the period of measurement. The statistical
significance of apparent differences between
the relative volume of various groups of
xenografts at a particular time after the start
of treatmnent was assessed using the Mann-
Whitney, non-parametric test for ranked
observations (Sokal & Rohlf, 1969).
The control group for Tumour HXK4 con-
sisted of 40 xenografts and the control group
for Tumour HXK7 consisted of 10, each
group being measured for 12 days. The
amines and amine-receptor antagonists ad-
mninistered to experimental groups of mice
are listed in the Table. Each experimental
group consisted of 5-6 mice bearing 9-12
xenografts. All drugs were given by i.p.
injection, and all treatments began on the
20th dav after implantation.
RESULTS
The influence of adrenergic ayonists and
antagonists
The administration of adrenaline, a
broad-spectrum a-, /3i- and 32-adrenergic
agonist, produced short-term suppression
of the growth of Xenograft Line HXK4,
mean tumour volume reaching a nadir on
the second day of treatment (Fig. 1). Con-
versely, treatment with sotalol, a 1l- and
f2-adrenergic antagonist, accelerated
tumour growth (Fig. 3). The phospho-
diesterase inhibitor, theophylline, pro-
longed the adrenaline-induced inhibition
TABLE. Biogenic amnines and related drugs tested for influence of xenograft growth (all
agents given by i.p. injection from the 20th day after implantation)
Agent
Clhemical nomenclature
Adrenaline 3,4-dihydroxy-x[(methylamino)
methyl]benzyl alcohol
Terbutaline 1-(3,5-dihydroxyphenyl)-2-tert-
butylamine etlhanol sulphate
Sotalol N-[4-[l -hydroxy-2[( i-methyl-
et,hyl)amino]et,hyl]phenyl]
methane sulphonamide
Practolol 4-(2-hydroxy-3-isopropyl-
aminoproxy) acetanilicle
Theoplhylline 1,3-dimethylxanthine
ethylenediamine
Serotonini 5-hydroxytryptamine creatiiiine
sulphate
BW 501C cx-anilino-N-2-clhlorphenoxy-
propyl chlorophenoxypropyl-
acetamidine hydrochloride
monohydrate
Dimiprit S-[3-(N,N-dimethylamino)
propyl]isothiourea
Cimeticline N"-cyano-N-metlhyl-N'-[2-(5-
methylimadaxol-4-yl)
metlhylthioethyl]guanidine
Plharmacological
actionis
a, l and P2 adrenergic
agonist
P2 adlrenergic agonist
and P2 adrenergic
antagonist
PI adrenergic antagonist,
adrenergic agonist, local
anaesthetic
Phosphodiesterase
inhibition, increase in
membrane permeability
to Ca--+
Serotoninergic agonist
Serotoninergic antagonist
Histarnine H2-receptor
agonist. Diamine
oxi(dase inhibitor
Histamine H2-receptor
antagonist
IDose
(mg/kg)
1-0
Schedule
(No. of
(loses/
day)
3
Tumour
tested
HXK 4
10 3 HXK 4
20 2 HXK 4
20 3
150 3
(01 3
0-01 3
5 3
HXK 4
HXK 4
HXK 4
HXK 4
HXK 4
1-0 31 HXK 4
5 3 HXK 4
HXK 7
Approved
pharmacological
nomenclature
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FIG. 1.-Graph of relative tumour volume vs
time after start of treatment. Tumour Line
HXK4. Control ....... Adrenaline
Adrenaline and theophylline *-*-*-*,
Terbutaline -. * Indicates a statis-
tically significant difference (P < 0-05) be-
tween the volume of control aiidl experi-
mental xenografts.
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FiG. 2. Graph of relatix-e tumouir v-olume vs
time after start of treatment. Tumour Line
HXK4. Control ....., Theophylline
-- -. No statistically significant liffer-
ence between the control and treated
xenografts.
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FiG. 3. Graph of relativ-e tumour volume vs
time after start of treatment. Tumour Line
HXK4. Control ....... Sotalol _ ,
Practolol ------. * Indicates a statistically
significant difference (P<0 05) between
control and experimental xenografts.
of tumour growth (Fig. 1) but theophylline
in the absence of xenogenous adrenaline
appears to have had little effect on tumour
growth (Fig. 2).
Administration of terbutaline, a selec-
tive fl2-adrenergic antagonist, produced
little if any inhibition of tumour growth
(Fig. 3) whereas practolol, a selective /l-
adrenergic antagonist, promoted tumour
growth to a similar extent to sotalol
(Fig. 3).
The influence of serotonergic agonist and a
serotoninergic antagonist
Treatment of mice with serotonin, at a
dose of either 0-01 or 041 mg/kg, failed to
l0 influence the rate of growth of Xenograft
HXK4 (Fig. 4). By contrast, the anti-
serotoninergic drug BW 501C had a small
inhibitory effect on Tumour HXK4 (Fig.
5) and a greater and more prolonged in-
hibitory effect on Tumour HXK7 (Fig. 6).
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FIG. 4. Graph of relative tumour volume v8
time after start of treatment. Tumour Line
HXK4. Control ....... Serotonin (0.1
mg/kg) -, Serotonin (0-01 mg/kg)
- - -. No statistically significant differ-
ences.
The influence of a histamine H2-receptor
agonist and a histamine H2-receptor antago-
nist
The histamine H2-receptor antagonist
Dimiprit appeared not to influence the
growth of Tumour HXK4 (Fig. 7). How-
ever, the histamine H2-receptor antagonist
cimetidine strongly inhibited the growth
of Tumour HXK4 (Fig. 5) and had a
slightly inhibitory effect on Tumour
HXK7 (Fig. 6).
DISCUSSION
These results clearly suggest that the
growth of human bowel cancer in xeno-
graft can be influenced by biogenic amines,
although many details of this influence
remain to be elucidated. However, even at
this stage, 3 issues seem to justify further
discussion. These are: first, the failure of
serotonin and Dimiprit to accelerate
tumour growth though their antagonists
inhibit tumour growth; secondly, the
DAYS
FIG. 5.-Graph of relative tumour volume V8
time after start of treatment. Tumour Line
HXK4. Control ....... BW 501C --- ,
Cimetidine -. * Indicates a statistic-
ally significant difference (P<0-05) be-
tween control and experimental xenograft.
possible role of cyclic nucleotides in the
regulation oftumour growth; and, thirdly,
the mechanism of tachyphylaxis to the
growth-inhibitory agents used.
Failure of treatment with serotonin or
Dimiprit to accelerate tumourgrowth may
be a feature of the doses used. In earlier
experiments on the influence of serotonin
on cell proliferation it was found that the
effect of this agent was highly dose-
dependent, low doses promoting cell
division whilst higher doses were ineffec-
tive or inhibitory (Tutton, 1974; Tutton
& Barkla, 1978a). In the case of hista-
minic agonists, specific desensitization of
receptors may rapidly follow exposure of
cells to high levels ofstimulants (Barsoum
& Gaddum, 1935). Alternatively, tumour
growth may already be maximally stimu-
lated by endogenous histamine or sero-
tonin.
Cyclic nucleotides have now been impli-
cated in the control of proliferation in a
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FIG. 6.-Graph of relative tumour volume vs
time after start of treatment. Tumour Line
HXK7. Control ....... BW 501C
Cimetidine -. * Indicates a statistic-
ally significant difference (P < 005) be-
tween control and experimental xenograft.
vast array of cell types. High intracellular
levels of cyclic guanosine monophosphate
(cGMP) or treatment with agents that
promote the formation of cGMP are asso-
ciated with rapid cell division in bacteria
(Benlohr et al., 1974), meristematic plant
cells and mammalian fibroblasts (Goldberg
et al., 1974), haemopoietic stem cells
(Byron, 1974), lymphocytes (Hadden et
al., 1970), granulocyte-macrophage pro-
genitor cells (Kurland et al., 1977),
epidermal cells (Voorhees et al., 1973) and
intestinal epithelial cells (Tutton, 1976).
Cyclic adenosine monophosphate (cAMP),
on the other hand, has been shown to
inhibit division in many cell types (for a
review see Whitfield et al., 1976) and is an
important mediator in the process of con-
tact inhibition of cell division (Pastan et
al., 1973). The results in the present com-
munication are compatible with the hypo-
thesis that tumour growth is promoted by
DAYS
FIG. 7.-Graph of relative tumour volume vS
time after start of treatment. Tumour Line
HXK4. Control .......Dimiprit*-*-*-.
No statistically significant difference exists.
intracellular cGMP, the synthesis ofwhich
is inhibited by blockade of serotonin or
histamine receptors. Conversely cAMP,
the synthesis of which is activated by
/3-adrenergic agonists such as adrenaline,
may inhibit tumour growth.
The rapid tachyphylaxis to injected
amines and amine antagonists which was
seen in the xenograft experiments may
have a pharmacological basis or may be
dependent upon selected growth of cells
which are resistant to the drugs used.
Xenografts may contain subpopulations
of cells with differing pharmacological
responses and thus, when growth of some
but not all of these subpopulations is even
permanently suppressed, tumour growth
will be resumed because ofrelative expan-
sion ofthe subpopulation ofresistant cells.
Pharmacological factorsthatcouldfeasibly
be responsible for the observed tachy-
phylaxis include changes in receptor sensi-
tivity or change in the activity of the
phosphodiesterases which are responsible
for degrading cyclic nucleotides. Changes
in receptor sensitivity after administra-
tion of amines has been most extensively
w
0
0
w
-LJ a:
747
I748 P. J. M. TUTTON AND G. G. STEEL
studied with respect to the influence of
/-adrenergic agonists on adenyl cyclase
activity. In this system desensitization
due to reduction in the number of func-
tioning drug receptors (Mukherjee et al.,
1975; Mickey et al., 1975), reduction in
receptor affinity (Lin et al., 1977) and
negative receptor-receptor cooperation
(Limbird et al., 1975) have been demon-
strated. In addition to membrane re-
ceptor changes, tachyphylaxis may be
mediated by a specific cAMP-phospho-
diesterase, the synthesis of which is in-
duced by high intracellular levels of
cAMP (Appleman & Terasaki, 1975). The
latter explanation does appear to be
relevant, at least for the observed tachy-
phylaxis to adrenaline, since a phospho-
diesterase inhibitor prolonged the sup-
pressive effect of this amine.
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